News

Weight-loss company Noom pivots to smaller doses of compounded Wegovy
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
STAT3d
Pharmalittle: We’re reading about FDA eyeing PDUFA changes, compounded weight loss drugs, and more
Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...
NJBIZ1d
Novo Nordisk expands Wegovy access as FDA bans semaglutide copies
Novo Nordisk boosts Wegovy access with discounts as FDA bans compounded semaglutide drugs and cracks down on weight-loss copycats.
The Tab7d
Ozempic vs Mounjaro: The difference between the celeb weight loss jabs they’re all using
Amy Schumer shares on Instagram that Mounjaro worked wonders for her weight loss and perimenopause symptoms, unlike Ozempic, ...
NJBIZ9d
Frier Levitt to host webinar on GLP-1 legal risks
Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...
Q&A on Trump’s Prescription Drug Pricing Executive Order
In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...
Reuters7d
From insulin to Ozempic, history of Novo Nordisk's CEOs
Under Sorensen, the company develops its first GLP-1 drug, a precursor to Ozempic and Wegovy. Liraglutide, a GLP-1 product for treatment of type 2 diabetes, enters phase 3 trials. Novo Nordisk ...